Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

by on 30 de gener de 2023 with No hi ha comentaris
  • Bailón, L., Llano, A., Cedeno, S., Escribà, T., Rosás-Umbert, M., Parera, M., . . . Paredes, R., Clotet, B., Noguera-Julián, M., Brander, C., Mothe, B., Grp, A. S. (2022). Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. Nature Medicine, 28(12), 2611-2621. https://doi.org/10.1038/s41591-022-02060-2

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *